The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Advances in Treatment of Locally Advanced or Metastatic Non–Small Cell Lung Cancer

Nature：非小细胞肺癌新靶点CLIP1-LTK被发现，劳拉替尼效果不错@MedSci

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Empire Genomics Interviews With Today's Leading Researchers & Clinicians

肺癌靶点研究渐露锋芒，源井生物基因编辑细胞助力肿瘤研究_源井生物

Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)

PDF) Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment—A Paradigm Shift in Oncology

Repotrectinib (TPX-0005) Datasheet